Interaction Guide · Research summary

Can I take Trigonella Foenum-Graecum with Acarbose?

Review Trigonella Foenum-Graecum with Acarbose: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Fenugreek warrants glucose review, but added hypoglycemia with acarbose has not been established. A small study reported a low-glucose event with fenugreek and metformin, which is indirect for this pair.

What this answer covers

Fenugreek capsules or traditional seed products; preparation and dose matter. Conventional oral acarbose scope.

Supplement or preparation
Trigonella foenum-graecum
Medication ingredient
acarbose

A small study reported a low

A trial comparing fenugreek with glibenclamide, each added to metformin, reported one hypoglycemia event in the fenugreek arm. Fasting-glucose improvement in that arm was not statistically significant.

The study did not test acarbose

The small sample and reporting limitations prevent a reliable exact-pair risk estimate. The event provides a reason for review but cannot demonstrate acarbose-specific potentiation.

Do not transfer every insulin warning

Acarbose acts by delaying carbohydrate digestion and alone should not cause hypoglycemia. Its effect in a selected reactive-hypoglycemia study was protective against post-sucrose lows. These facts do not prove every herb combination safe.

Keep a suitable monitoring plan

Tell the diabetes team about medicinal fenugreek use and follow the agreed glucose plan. If low-glucose treatment is needed, acarbose changes the choice of sugar: glucose is preferred to sucrose for appropriate oral rescue. Do not change prescribed drugs on your own.

Evidence and practical considerations

Side effects & toxicity

Fenugreek/metformin low-glucose report is indirect; exact acarbose additive hypoglycemia unestablished, with drug-specific mechanism retained.

Exact scope
Fenugreek capsules or traditional seed products; preparation and dose matter. Conventional oral acarbose scope. with Oral acarbose RxCUI16681 IN; conventional tablets, local intestinal action.
Medication form and route
oral medication; oral supplement

What remains uncertain

  • No arbitrary interval, systemic-exposure inference or unmeasured exact event rate.

Factors that may matter: Preparation; Meal timing; Dose; Other diabetes treatment.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral acarbose

Local intestinal carbohydrate-digestion inhibition; less than2% absorbed as active drug. Alone should not cause hypoglycemia; insulin/sulfonylurea co-use can increase risk. Oral glucose, not sucrose, for appropriate mild-to-moderate lows. Charcoal adsorbents and carbohydrate-splitting enzymes may reduce effect and should not be taken concomitantly.

How this applies: Exact conventional oral acarbose; controlled-release combination products distinguished.

General warnings do not establish each botanical interaction or arbitrary timing gap. Low systemic absorption is expected, not proof of treatment failure.

Source 2: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Small uncontrolled-diabetes cohort.

Fasting-glucose reduction with fenugreek not significant; one hypoglycemia event reported in fenugreek/metformin arm.

How this applies: Exact acarbose preparation and supplement identity/outcome boundaries retained.

Very small study, only9of12completed per results; reporting includes inconsistent completion wording. Not acarbose co-use and no exact-pair event rate.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 24patients in three reactive-hypoglycemia groups.

Reduced magnitude of post-sucrose reactive hypoglycemia and insulin responses.

How this applies: Exact acarbose preparation and supplement identity/outcome boundaries retained.

Selected reactive-hypoglycemia patients; prevention experiment, not acute rescue test or herbal co-use.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact acarbose article distinguishing local action, rescue sugar, formulation and original clinical findings.
Research summary published

Article revision: 26cc0b770e9fc336

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.